Telomerase activity in acute myelogenous leukaemia: Clinical and biological implications

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 156-165

  Seol, Jae Goo ^a   Kim, Eun Shil ^a   Park, Woo Hyun ^a   Jung, Chel Won ^b   Kim, Byoung Kook ^a   Lee, Young Yiul ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

AML; CD34+; Clinical response; Telomerase; Vitamin D3

Indexed keywords

CALCITRIOL; CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN; LEXACALCITOL; PROTEIN P21; SEOCALCITOL; TELOMERASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER REGRESSION; CLINICAL ARTICLE; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS REGULATION;

ADULT; AGED; ANTIGENS, CD34; CHOLECALCIFEROL; FEMALE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0008789548     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00524.x     Document Type: Article

References (43)

1. Albanell, J., Han, W., Mellado, B., Gunawardane, R., Scher, H.I., Dmitrovsky, E. & Moore, M.A.S. (1996) Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Research, 56, 1503-1508.
2. Allsopp, R.C., Varizi, H., Patterson, C., Goldstein, S., Younglai, E.V., Futcher, B.A., Greider, C.W. & Harley, C.B. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 89, 10114-10118.
3. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British (FAB) Cooperative Group. Annals of Internal Medicine, 33, 451-458.
4. Bestilny, L.J., Brown, C.B., Miura, Y., Robertson, L.D. & Riabowol, K.T. (1996) Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Research, 56, 3796-3802.
5. Blackburn, E.H. (1991) Structure and function of telomeres. Nature, 350, 569-573.
6. Broccoli, D., Young, J.W. & de Lange, T. (1995) Telomerase activity in normal and malignant hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America, 92, 9082-9086.
7. Campling, B.G., Pym, J., Galbraith, P.R. & Cole, S.P.C. (1988) Use of the MTT assay for rapid determination of chemosensitivity of human Ieukemic blast cells. Leukemia Research, 12, 823-831.
8. Chui, C.P., Dragowska, W., Kim, N.W., Vaziri, H., Yui, J., Thomas, T.E., Harley, C.B. & Lansdorp, P.M. (1996) Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells, 14, 239-248.
9. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B. & Bacchetti, S. (1992) Telomere shortening associated with chromosome instability in immortal cells which express telomerase activity. EMBO Journal, 11, 1921-1929.
10. Counter, C.M., Botelho, F., Harley, C.B. & Bacchetti, S. (1994a) Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. Journal of Virology, 68, 3410-3414.
11. Counter, C.M., Gupta, J., Harley, C.B., Leber, B. & Bacchetti, S. (1995) Telomerase activity in normal leukocytes and: in hematologic malignancies. Blood, 85, 2315-2320.
12. Counter, C.M., Hirte, H.W., Bacchetti, S. & Harley, C.B. (1994b) Telomerase activity in human ovarian carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 91, 2900-2904.
13. de Lange, T. (1994) Activation of telomerase in a human tumor. Proceedings of the National Academy of Sciences of the United States of America, 91, 2882-2885.
14. de Lange, T., Shiue, L., Myers, R.M., Cox, D.R., Naylor, S.L., Killery, A.M. & Varmus, H.E. (1990) Structure and variability of human chromosome ends. Molecular and Cellular Biology, 10, 518-527.
15. Greider, C.W. & Blackburn, E.H. (1985) Identification of a specific telomere terminal extrachromosomal RNA genes in Tetrahymena extracts. Cell. 43, 405-413.
16. Harley, C.B., Futcher, A.B. & Greider, C.W. (1990) Telomeres shorten during aging of human fibroblasts. Nature, 345, 458-460.
17. Harley, C.B., Kim, N.W., Prowse, K.R., Weinrich, S.L., Hirsch, K.S., West, M.D., Bacchetti, S., Hirte, H.W., Counter, C.M., Greider, C.W., Piatyszek, M.A., Wright, W.E. & Shay, J.W. (1994) Telomerase, cell immortality, and cancer. Cold Spring Harbor Symposia on Quantitative Biology, 59, 307-315.
18. Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M.A., Shay, J.W., Ishioka, S. & Yamakido, M. (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. Journal of Immunology, 155, 3711-3715.
19. Holt, S.E., Wright, W.E. & Shay, J.W. (1996) Regulation of telomerase activity in immortal cell lines. Molecular and Cellular Biology, 16, 2932-2939.
20. Jiang, H., Lin, J., Su, Z.Z., Collart, E.R., Huberman, E. & Fisher, P.B. (1994) Induction of differentiation in human promyelocytic HL-60 cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9, 3397-3406.
21. 3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leukemia Research, 18, 453-463.
22. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L.C., Coviello, G.M., Wright, W.E., Weinrich, S.L. & Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
23. Koeffler, H.P. (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood, 62, 709-721.
24. Krause, D.S., Fackler, M.J., Civin, C.I. & May, W.S. (1996) CD 34: structure, biology, and clinical utility. Blood, 87, 1-13.
25. 3 analog, EB1089. on hematopoietic stem cells from normal and myeloid leukemic blasts. Leukemia, 10, 1751-1757.
26. Levy, M.Z., Allsop, R.C., Futcher, A.B., Greider, C.W. & Harley, C.B. (1992) Telomere end-replication problem and cell aging. Journal of Molecular Biology, 225, 951-960.
27. Macleod, K.F., Sherry, N., Hannon, G., Beach, G., Tokino, T., Kinzler, K.W., Vogelstein, B. & Jacks, T. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation. and DNA damage. Genes and Development, 9, 935-944.
28. Mantell, L.L. & Greider, C.W. (1994) Telomerase activity in germline and embryonic cells of Xenopus. EMBO Journal, 13, 3211-3217.
29. Morin, G.B. (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesies TTAGGG repeats. Cell, 59, 521-529.
30. Nilsson, P., Mehle, C., Remes, K. & Roos, G. (1994) Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene, 9, 3043-3048.
31. Powell, B.L., Gregory, B.W., Kute, T.E., Morgan, T.M., Lyerly, E.S. & Capizzi, R.L. (1990) Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent. Cytometry, 11, 438-441.
32. Rhyu, M.S. (1995) Telomeres, telomerase, and immortality. Journal of the National Cancer Institute, 87, 884-894.
33. Savoysky, E., Yoshida, K., Ohtomo, T., Yamaguchi, Y., Akamatsu, K.I., Yamazaki, T., Yoshida, S. & Tsuchiya, M. (1996) Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochemical and Biophysical Research Communications, 226, 329-334.
34. Sharma, H.W., Sokoloski, J.A., Perez, J.R., Maltese, J.Y., Sartorelli, A.C., Stein, C.A., Nichols, G., Khaled, Z., Telang, N.T. & Narayanan, R. (1995) Differentiation of immortal cells inhibits telomerase activity. Proceedings of the National Academy of Sciences of the United States of America, 92, 12343-12346.
35. Shay, J.W., Werbin, H. & Wright, W.E. (1996) Telomeres and telomerase in human leukemias. Leukemia, 10, 1255-1261.
36. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A. & El-Houseini, M.E. (1994) Induction of p21 (WAF1/CIP1) during differentiation. Oncogene, 9, 3389-3396.
37. Vogelstein, B. & Kinzler, K. (1993) The multistep nature of cancer. Trends in Genetics, 9, 138-141.
38. Watson, J.D. (1972) Origin of concatemeric T7 DNA. Nature New Biology, 239, 197-201.
39. Weng, N.P., Levine, B.L., June, C.H. & Hodes, R.J. (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. Journal of Experimental Medicine, 183, 2471-2479.
40. Wright, E.W. & Shay, J.W. (1992) Telomere positional effects and the regulation of cellular senescence. Trends in Genetics, 8, 193-197.
41. Zhang, W., Grasso, L., McCain, C.D., Gambel, A.M., Cha, Y., Travail, S., Deisseroth, A.B. & Mercer, W.E. (1995) p53-independent induction of WAF1/Cip1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Research, 55, 668-674.
42. Zhang, W., Piatyszek, M.A., Kobayashi, T., Estey, E., Andreeff, M., Deisseroth, A.B., Wright, W.E. & Shay, J.W. (1996) Telomerase activity in human acute myelogenous leukemia inhibition of telomerase activity by differentiation-inducing agents. Clinical Cancer Research, 2, 799-803.
43. Zhu, X., Kumar, R., Mandal, M., Sharma, N., Sharma, H.W., Dhingra, U., Sokoloski, J.A., Hsiao, R. & Narayanan, R. (1996) Cell cycle-dependent modulation of telomerase activity in tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 93, 6091-6095.